ArticlePharmaceutics2024

New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease.

Leo Bon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.